Market Cap 4.97B
Revenue (ttm) 4.79B
Net Income (ttm) -317.00M
EPS (ttm) N/A
PE Ratio 23.39
Forward PE 21.80
Profit Margin -6.62%
Debt to Equity Ratio 0.73
Volume 425,705
Avg Vol 720,326
Day's Range N/A - N/A
Shares Out 352.47M
Stochastic %K 10%
Beta 0.54
Analysts Sell
Price Target $19.00

Latest News on BLCO

Bausch Health Provides Update on Strategic Alternatives

Feb 6, 2025, 7:05 AM EST - 7 weeks ago

Bausch Health Provides Update on Strategic Alternatives

BHC


Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid

Oct 14, 2024, 12:20 PM EDT - 6 months ago

Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid


Overlooked Stock: BLCO

Sep 16, 2024, 5:07 PM EDT - 7 months ago

Overlooked Stock: BLCO


Bausch + Lomb Stock Jumps Amid Reports Of A Sale

Sep 16, 2024, 1:16 PM EDT - 7 months ago

Bausch + Lomb Stock Jumps Amid Reports Of A Sale


Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results

May 29, 2024, 4:30 PM EDT - 11 months ago

Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results


Bausch + Lomb Announces First-Quarter 2024 Results

May 1, 2024, 6:58 AM EDT - 1 year ago

Bausch + Lomb Announces First-Quarter 2024 Results


Bausch & Lomb's stock soars 11% after earnings beat

Feb 21, 2024, 8:27 AM EST - 1 year ago

Bausch & Lomb's stock soars 11% after earnings beat


SparingVision appoints Joseph C. Papa as Chairman

Apr 5, 2023, 7:00 AM EDT - 2 years ago

SparingVision appoints Joseph C. Papa as Chairman

NTLA


Bausch + Lomb beats Q4 profit and revenue estimates

Feb 22, 2023, 7:14 AM EST - 2 years ago

Bausch + Lomb beats Q4 profit and revenue estimates

BHC


Bausch + Lomb: Still A Favorable Risk-To-Reward Prospect

Jan 24, 2023, 12:13 PM EST - 2 years ago

Bausch + Lomb: Still A Favorable Risk-To-Reward Prospect